Monday, September 7, 2026  ·  Covering: Fri–Mon this weekend

TL;DR

A quiet deal weekend as bankers hold their breath for the Sept 15–16 Fed meeting, where a rare rate hike is now a coin-flip under new Chair Kevin Warsh. The headline mover was CRH's $8.5B all-cash purchase of Arcosa clearing its shareholder vote Friday, cementing a wave of consolidation in US aggregates and infrastructure materials. In tech, Broadcom's blowout quarter (AI chip sales up 221%) and Nvidia's $3.5B convertible bet on MediaTek both underline that the AI-infrastructure buildout — and the financing it demands — is still the market's dominant story.

TOP 3 DEALS

DEAL 01

Industrials / Infrastructure

TRANSACTION VALUE~$8.5B, all-cash ($150/sh)

TERMS25% premium; ~11.5x 2026E EBITDA; closes Q1 2027

BUYER ADVISORS (CRH)J.P. Morgan, Morgan Stanley

SELLER ADVISORS (ARCOSA)Evercore, Goldman Sachs

CRH, the world's largest building-materials company, is buying Arcosa — a US maker of aggregates (crushed stone, sand, gravel) and critical infrastructure products. Arcosa shareholders approved the deal Friday (Sep 4), clearing a key hurdle toward a targeted Q1 2027 close.

Why it matters for IB recruiting: A clean all-cash strategic acquisition with disclosed multiples (11.5x EBITDA) and a 25% premium is exactly the kind of deal you can walk through end-to-end in an interview. It also rides the "infrastructure supercycle" thesis — federal spending plus data-center buildout driving demand for aggregates — a strong industrials-coverage talking point.

DEAL 02

Tech / Semiconductors

INVESTMENT SIZE$3.5B (of $3.9B convert offering)

STRUCTUREZero-coupon converts, 5-yr, minority stake

STRATEGIC TERMSMediaTek adopts Nvidia's NVLink Fusion

ADVISORSAdvisors TBD

Nvidia bought $3.5B of MediaTek convertible bonds — debt that can flip into equity later — tying the Taiwanese chip designer into Nvidia's ecosystem for building custom AI accelerators. The two will also collaborate on PC and automotive chips.

Why it matters for IB recruiting: This is a live example of a convertible-bond financing and a strategic minority investment rather than a full takeover — great for showing you understand the financing toolkit beyond plain M&A. It also illustrates how Nvidia is defending its moat even as big customers design their own silicon, a sharp TMT thesis to raise.

DEAL 03

Industrials / Electronics

TRANSACTION VALUE~$1.4B

STRUCTUREStrategic buys sponsor asset (from Tinicum)

BUYER ADVISORS (TE)Advisors TBD

SELLER ADVISORS (TINICUM)Advisors TBD

TE Connectivity, a major maker of connectors and sensors, is buying Astrodyne TDI — a supplier of power-conversion and electromagnetic filtering components — from private-equity owner Tinicum. It's a bolt-on that deepens TE's exposure to power-hungry data-center and industrial applications.

Why it matters for IB recruiting: Another strategic-buys-from-sponsor deal, sized in the "core M&A" range where most analyst deal experience actually happens. Power and thermal management for AI data centers is a fast-growing sub-theme within industrials — worth having a view on.

SECTOR SIGNAL

TECH / TMT

Broadcom crushed Q3: revenue +86% to $29.6B and AI chip sales +221% to $16.7B, with guidance to $115B of AI revenue by FY27 — the clearest read yet on custom-silicon demand. CNBC ↗

INDUSTRIALS

Industrial-manufacturing M&A has reached $164B through mid-2026, with mega-deals (>$5B) now 56% of deal value — the CRH/Arcosa close fits squarely in that big-ticket consolidation trend. PwC ↗

HEALTHCARE

Eli Lilly opened September buying private biotech Merida Biosciences (autoimmune/allergy therapeutics) on Sep 1, and Frazier Healthcare struck a $490M deal for MatrixCare — biopharma and medtech keep driving a busy healthcare M&A tape. Xtalks ↗

ENERGY

Power-demand-driven dealmaking keeps building, with NextEra's proposed ~$67B Dominion Energy tie-up still the sector's marquee pending deal as data-center load reshapes utility M&A. Wiki ↗

M&A

A slow weekend for new announcements as dealmakers wait on the Fed, but the pipeline stays deep — mega-deals above $5B are now the majority of 2026 deal value, and both strategics (CRH, TE) and sponsors keep trading assets. Capital-Riesgo ↗

RESTRUCTURING

Chapter 11 filings hit a decade high in 2025 and are set to stay elevated, with borrowers increasingly using out-of-court liability management exercises (LMEs) to buy time — though many just defer an eventual filing. PwC ↗

ECM

The equity calendar is thin but reopening — roughly 4 IPOs are slated to price the week of Sep 6–12, a cautious sign issuers are testing the window ahead of the Fed. IPOScoop ↗

DCM

Investment-grade issuers are lining up a heavy September — Street estimates run $175–250B for the month — and even the high end is seen as digestible given strong demand; 2026 primary volume is on pace to top $2T. Bloomberg ↗

MARKET TONE

  • All eyes on Sept 16. The FOMC decides Wednesday, Sep 16 at 2pm ET, with a fresh "dot plot." Odds of a 25bp hike ran near 57% after Chair Warsh's hawkish Jackson Hole speech — a stunning shift from the cut consensus earlier this year. FedRateCalc ↗

  • Rates still elevated. The target range sits at 3.50–3.75%, unchanged since the last cut in December 2025, as the Fed waits for cleaner evidence inflation is easing. FedRateCalc ↗

  • AI keeps carrying earnings. Broadcom's blowout (AI revenue +221%) reinforced that hyperscaler capex is still accelerating, a key support under mega-cap equities. Motley Fool ↗

  • Seasonality headwind. September is historically the S&P 500's weakest month, and the Fed meeting lands right at the point the pattern tends to turn — expect choppy, headline-driven trading. Benzinga ↗

  • Financing still open — for now. Big acquisition financing (CRH's all-cash $8.5B, Nvidia's $3.5B convert) is still getting done, but a hawkish Fed surprise would raise the cost of the debt that fuels LBOs and strategic deals alike. White & Case ↗

INTERVIEW ANGLE

TOPIC: WHY A STRATEGIC PAYS CASH VS. ISSUES A CONVERTIBLE

This weekend gave you two contrasting ways buyers fund a deal — CRH paying $8.5B all-cash for Arcosa, and Nvidia deploying $3.5B via convertible bonds into MediaTek. Being able to explain the trade-off is a clean, senior-sounding answer:

  • All-cash (CRH): Maximum certainty and speed for sellers, no dilution to CRH shareholders — but it uses balance-sheet cash or new debt, and in a high-rate environment that debt is expensive. Signals confidence in the target's cash flows.

  • Convertible (Nvidia): A bond that can convert into equity later. It's cheaper day-one financing (Nvidia's carried a zero coupon), lets Nvidia take a strategic stake without an outright acquisition, and defers dilution until/unless the stock rises. Ideal for a partnership rather than control.

  • The through-line: Capital structure follows intent — control and certainty push toward cash; optionality and partnership push toward converts or minority stakes.

How to bring it up: "Two deals this weekend showed the financing spectrum nicely — CRH went all-cash for Arcosa to lock up control, while Nvidia used a convertible to take a strategic stake in MediaTek without buying it outright. I think the choice of consideration tells you a lot about what the buyer actually wants from the deal."